-
effectivehealthcare-admin.ahrq.gov/products/ace-inhibitor-arb-future/research
March 01, 2020 - Advances in antihypertensive therapy have dramatically reduced cardiovascular, cerebrovascular, and renal … strengthen the conclusions regarding long-term cardiovascular outcomes, quality of life, progression of renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
June 01, 2011 - Number 34
Effective
Health Care
2
The renin system can be triggered by sympathetic
stimulation, renal … used extensively for treatment of hypertension,
heart failure, myocardial infarction, diabetes, and renal … There appears to be a small difference in change in
diabetes control, renal function between ACEIs and … and
switch rates).
• Specific adverse events (including, but not limited to, weight gain, impaired renal … e Specific adverse events: These included, but were no limited to, weight gain, impaired renal function
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
February 01, 2011 - Chronic renal disease affects more than 26 million Americans1
and is the cause of significant morbidity … a common complication, conveys signifi-
cant risk for cardiovascular disease, faster progression of renal … failure, and decreased quality of life.3 In fact, most patients
with chronic renal disease become … Early Anemia Treatment
With Epoetin Beta [CREATE] 7 and
Correction of Hemoglobin and Outcomes
in Renal … Anemia in renal
disease: diagnosis and management. Blood
Rev 2010;24(1):39-47.
4. Nurko S.
-
effectivehealthcare-admin.ahrq.gov/health-topics/vascular-diseases?page=0
June 21, 2018 - ACS) Depression: A Systematic Review
Systematic Review Archived August 16, 2016
Renal … Monotherapy and Add-on Therapy to Metformin
Research Protocol Archived January 20, 2015
Renal
-
effectivehealthcare-admin.ahrq.gov/health-topics/vascular-diseases
June 21, 2018 - ACS) Depression: A Systematic Review
Systematic Review Archived August 16, 2016
Renal … Monotherapy and Add-on Therapy to Metformin
Research Protocol Archived January 20, 2015
Renal
-
effectivehealthcare-admin.ahrq.gov/health-topics/blood-disorders
July 26, 2016 - Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal … Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage Renal
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-treatment/abstract
December 01, 2019 - Outcomes – a) development of CVD (acute myocardial infarction and stroke), CKD (including End Stage Renal … CVD and CKD; b) progression of CVD (acute myocardial infarction and stroke), CKD (including End Stage Renal
-
effectivehealthcare-admin.ahrq.gov/products/cancer-pancreas/research
December 01, 2019 - Treatment of Tethered Spinal Cord
Clinician Summary
ARCHIVED
Jul 18, 2017
Management of Renal … Masses and Localized Renal Cell Carcinoma: Current State of the Evidence
Clinician Summary
-
effectivehealthcare-admin.ahrq.gov/health-topics/heart-diseases?page=0
June 21, 2018 - ACS) Depression: A Systematic Review
Systematic Review Archived August 16, 2016
Renal … Monotherapy and Add-on Therapy to Metformin
Research Protocol Archived January 20, 2015
Renal
-
effectivehealthcare-admin.ahrq.gov/health-topics/heart-diseases
June 21, 2018 - ACS) Depression: A Systematic Review
Systematic Review Archived August 16, 2016
Renal … Monotherapy and Add-on Therapy to Metformin
Research Protocol Archived January 20, 2015
Renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - Harms: hypertension, congestive heart failure
(CHF), edema, and impaired renal function
• All NSAIDs … Evidence regarding the
comparative risk of renal dysfunction for celecoxib
and rofecoxib is sparse. … event (peripheral edema, hypertension, or
renal dysfunction) risk from 114 randomized trials
of COX- … , although
there was no difference for the prepecified,
primary composite renal outcome of peripheral … edema, hypertension, renal dysfunction, or
arrhythmia.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
January 01, 2013 - Completion Date: 02-13-2013
3
Control and Complications Trial (DCCT) (as measured by retinal, renal … A decrease in or prevention of diabetes-related complications (as measured by retinal,
renal, cardiovascular
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
January 07, 2016 - whether imaging was done on an
urgent or elective basis, or other details such
as the severity of renal … We know that CIN incidence varies dramatically based on baseline
renal function, and the absence of … It is hypothesized that patients with normal or near-normal renal
function "may have" a lower risk of … resulting from changes in
creatinine production, tubular secretion, volue of distribution or extra-renal … Need for renal replacement therapy is
addressed in all comparisons.
-
effectivehealthcare-admin.ahrq.gov/health-topics/atherosclerosis
March 29, 2016 - Research Protocol Archived June 13, 2013
Troponin Cardiac Marker Interpretation During Renal … Systematic Review Archived October 24, 2006
Comparative Effectiveness of Management Strategies for Renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - with DES plus a selected group of clinically important variables including: gender,
age, diabetes, renal … As expected, mortality was higher in those with diabetes, renal failure,
STEMI or CHF. … This effect was somewhat less pronounced in those with a prior history of CABG and
renal failure, with … Similarly, the
30-month risk of MI was lower in all patient subgroups except those with renal failure … (Figure 4c) However, no benefit was
observed in patients >75 years, or with diabetes, renal failure,
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-drugs-utilization/research
December 01, 2019 - Metformin is also frequently avoided in older adults due to declines in renal function as indicated by … sulfonylurea use in older adults is associated with increased risk of hypoglycemia also due to decreasing renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
November 01, 2013 - The BNP concentration
was inversely related to renal function. … Renal function: Two papers48,80 reported an inverse
association between renal function and NT-proBNP … Renal function: One study assessed the effect of renal
function on test performance.101 Patients were … function: One study101 examined the effect of
renal function on the ability of NT-proBNP to identify … of both BNP and NT-proBNP, and to establish cutpoints
in situations of reduced renal function
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - I demanded from the owner of my medical
center that I immediately be referred to a renal nutritionist … Renal Data System (USRDS) and the
Behavioral Risk Factor Surveillance System (BRFSS). … Ruben Velez
Renal Physicians
Association
In asymptomatic adults with or without recognized risk … A recent study by the Chronic Renal Insufficiency Cohort
(CRIC) Study Group showed that treatment of … Diuretics, calciuria and secondary hyperparathyroidism in
the Chronic Renal Insufficiency Cohort.
-
effectivehealthcare-admin.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol
December 01, 2019 - resulting end-organ damage, including skeletal destruction (lytic bone lesions), hypercalcemia, anemia, and renal … Bone marrow plasma cells ≤10%
Absence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … urinary monoclonal protein
Evidence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … bone marrow plasma cells ≥10%
Absence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … amyloidosis
Amyloid-related systemic syndrome — organ involvement by tissue amyloid deposition (renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
October 01, 2009 - presence and
pattern of symptoms), dose of the ACE inhibitor or
ARB used, comorbidities (diabetes, renal … Patients with renal dysfunction have at least
as robust relative reductions in the risk of cardiovascular … Renal impairment Moderate • Combination of ACE inhibitor + ARB (ramipril +
withdrawal telmisartan) has … more discontinuations due to renal
impairment than ACE inhibitor (ramipril) alone. … Renal impairment Insufficient • No data are available evaluating ACE inhibitors or ARBs
or hyperkalemia